<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2012-04-04 15:36:14Intensive care medicine Hypertension Bronchopulmonary dysplasia Nitric oxide Pulmonary hypertension Preterm birth Extracorporeal membrane oxygenation Medicine Health Chemistry |
|
IKARIA® COMPLETES PATIENT ENROLLMENT IN PIVOTAL PHASE III TRIAL FOR BRONCHOPULMONARY DYSPLASIA -- Enrollment Concludes Ahead of Schedule -- Hampton, NJ – February 27, 2012 – Ikaria, Inc., a critical care company foc